-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GNdD6pgj1IJXlmEV7TJAJaNMR8gypGdy/9Pg73GcGWchZYvqmKKMEP1+VM6WuUwc 0L7QEhxwSWHwWyM58kZEOA== 0001144204-10-011193.txt : 20100419 0001144204-10-011193.hdr.sgml : 20100419 20100303144422 ACCESSION NUMBER: 0001144204-10-011193 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980376008 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 BUSINESS PHONE: 011 972-54-7909058 MAIL ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 CORRESP 1 filename1.htm
ORAMED PHARMACEUTICALS INC.
Hi-Tech Park 2/5
PO Box 39098
Jerusalem 91390, Israel
 

                March 3, 2010
 
VIA EDGAR AND FACSIMILE
 
Securities and Exchange Commission
Mail Stop 4720
100 F Street, N.E.
Washington, D.C.  20549
Attention:  Nandini Acharya, Esq., Division of Corporation Finance
 
Re:
Oramed Pharmaceuticals Inc.
 
Registration Statement on Form S-1, filed January 11, 2010, as amended
 
SEC File No. 333-164288                                 

 
Dear Ms. Acharya:
 
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, it is hereby requested that the effective date of the above-referenced Registration Statement on Form S-1 of Oramed Pharmaceuticals Inc. (the “Company”) be accelerated and that the Registration Statement become effective at 4:30 P.M. on March 3, 2010, or as soon thereafter as possible.
 
In connection with the foregoing acceleration request, the Company acknowledges that:
 
 
w
Should the Securities and Exchange Commission (“Commission”) or its staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
     
 
w
The action of the Commission or its staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the accuracy and adequacy of the disclosure in the Registration Statement; and 
 
 
w
The Company may not assert the action of the Commission or its staff in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
 
 
Very truly yours,
   
 
ORAMED PHARMACEUTICALS INC.
   
 
By:  /s/ Yifat Zommer                     
 
Yifat Zommer
 
Chief Financial Officer

 
 
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----